834 related articles for article (PubMed ID: 1362634)
1. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
[TBL] [Abstract][Full Text] [Related]
2. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
[TBL] [Abstract][Full Text] [Related]
4. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
6. Role of CD8+ in late opportunistic infections of patients with AIDS.
Fiala M; Kermani V; Gornbein J
Res Immunol; 1992; 143(9):903-7. PubMed ID: 1363252
[TBL] [Abstract][Full Text] [Related]
7. Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds.
Dworkin MS; Hanson DL; Kaplan JE; Jones JL; Ward JW
J Infect Dis; 2000 Aug; 182(2):611-5. PubMed ID: 10915098
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
[TBL] [Abstract][Full Text] [Related]
9. Sources of disseminated Mycobacterium avium infection in AIDS.
von Reyn CF; Arbeit RD; Horsburgh CR; Ristola MA; Waddell RD; Tvaroha SM; Samore M; Hirschhorn LR; Lumio J; Lein AD; Grove MR; Tosteson AN
J Infect; 2002 Apr; 44(3):166-70. PubMed ID: 12099743
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
[TBL] [Abstract][Full Text] [Related]
12. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
Stambuk D; Hawkins D; Gazzard BG
J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
Cooper DA; Pehrson PO; Pedersen C; Moroni M; Oksenhendler E; Rozenbaum W; Clumeck N; Faber V; Stille W; Hirschel B
AIDS; 1993 Feb; 7(2):197-207. PubMed ID: 8096703
[TBL] [Abstract][Full Text] [Related]
14. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
Nightingale SD; Jockusch JD; Haslund I; Cal SX; Peterson DM; Loss SD
Arch Intern Med; 1993 Jun; 153(11):1313-8. PubMed ID: 8099477
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
[TBL] [Abstract][Full Text] [Related]
16. Severe anemia is an important negative predictor for survival with disseminated Mycobacterium avium-intracellulare in acquired immunodeficiency syndrome.
Sathe SS; Gascon P; Lo W; Pinto R; Reichman LB
Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1306-12. PubMed ID: 2252248
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Fischl MA; Parker CB; Pettinelli C; Wulfsohn M; Hirsch MS; Collier AC; Antoniskis D; Ho M; Richman DD; Fuchs E
N Engl J Med; 1990 Oct; 323(15):1009-14. PubMed ID: 1977079
[TBL] [Abstract][Full Text] [Related]
18. Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000.
Horsburgh CR; Gettings J; Alexander LN; Lennox JL
Clin Infect Dis; 2001 Dec; 33(11):1938-43. PubMed ID: 11692307
[TBL] [Abstract][Full Text] [Related]
19. [Mycobacterium avium-intracellulare disseminated infection in patients with AIDS].
Herrero Martínez JA; Sánchez Manzano MD; Palenque Mataix E; Medina Iglesias P; Sánchez Rivas JL; Rubio García R; Costa Pérez-Herrero JR
Med Clin (Barc); 1993 Feb; 100(5):171-3. PubMed ID: 8450695
[TBL] [Abstract][Full Text] [Related]
20. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]